首页 工具
登录
购物车

搜索结果

Search Results for " 托法替尼 "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T6321 Tofacitinib

托法替尼,Tasocitinib,CP-690550

ROCK; Apoptosis; JAK; Src Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
Tofacitinib (Tasocitinib) 是口服小分子 Janus 激酶抑制剂,用于治疗中度至重度类风湿性关节炎。
T2398 Tofacitinib Citrate

CP-690550 citrate,柠檬酸托法替尼,枸橼酸托法替尼,Tasocitinib citrate,Tofacitinib (CP-690550) Citrate

Apoptosis; Influenza Virus; JAK; Antibacterial; Antifungal Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Microbiology/Virology; Stem Cells
Tofacitinib Citrate (CP-690550 citrate) 是 JAK1/2/3抑制剂,IC50分别为112,20 和 1 nM。它具有抗菌,抗真菌和抗病毒活性。
T13426L (3S,4S)-Tofacitinib

(3S,4S)-托法替尼

Others Others
(3S,4S)-Tofacitinib, a less active enantiomer of tofacitinib, is a Janus kinases inhibitor.
T13426 (3R,4S)-Tofacitinib

Others Others
(3R,4S)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM).
T13427 (3S,4R)-Tofacitinib

Others Others
(3S,4R)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM).
T72406 Tofacitinib Prodrug-1

Tofacitinib Prodrug-1 是减轻托法替尼 (Tofacitinib) 全身性不良反应的口服有效前药。Tofacitinib Prodrug-1 能在小鼠模型有效减轻恶唑酮诱导的结肠炎,具有低毒性,是治疗溃疡性结肠炎的潜在候选药物。

化合物

Tofacitinib
Cat.No: T6321
Synonym: 托法替尼,Tasocitinib,CP-690550
Target: ROCK, Apoptosis, JAK, Src
Tofacitinib Citrate
Cat.No: T2398
Synonym: CP-690550 citrate,柠檬酸托法替尼,枸橼酸托法替尼,Tasocitinib citrate,Tofacitinib (CP-690550) Citrate
Target: Apoptosis, Influenza Virus, JAK, Antibacterial, Antifungal
(3S,4S)-Tofacitinib
Cat.No: T13426L
Synonym: (3S,4S)-托法替尼
Target: Others
(3R,4S)-Tofacitinib
Cat.No: T13426
Synonym:
Target: Others
(3S,4R)-Tofacitinib
Cat.No: T13427
Synonym:
Target: Others
Tofacitinib Prodrug-1
Cat.No: T72406
Synonym:
Target:
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼